# EDGAR Filing Document

**Accession Number:** 0001954488
**File Stem:** 0001213900-25-053878
**Filing Date:** 2025-6
**Character Count:** 2824
**Document Hash:** 101deaff420c680f5a0833865fc35d8e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-053878.hdr.sgml**: 20250807

**ACCESSION NUMBER**: 0001213900-25-053878

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250612

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Jyong Biotech Ltd.
- **CENTRAL INDEX KEY:** 0001954488
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** E9

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 23F-3, NO.95, SEC. 1, XINTAI 5TH RD.
- **STREET 2:** XIZHI DIST.
- **CITY:** NEW TAIPEI CITY
- **STATE:** F5
- **ZIP:** 221
- **BUSINESS PHONE:** (8862) 27325205

**MAIL ADDRESS:**
- **STREET 1:** 23F-3, NO.95, SEC. 1, XINTAI 5TH RD.
- **STREET 2:** XIZHI DIST.
- **CITY:** NEW TAIPEI CITY
- **STATE:** F5
- **ZIP:** 221

**Jyong Biotech Ltd.**

**23F-3, No. 95, Section 1, Xintai 5th Road** 

**Xizhi District, New Taipei City**

**Taiwan, 221**

June 12, 2025

**<u>VIA EDGAR</u>**

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Ms. Doris Stacey Gama/ Ms. Suzanne Hayes

---

| | |
|:---|:---|
| **Re:** | **Jyong Biotech Ltd.** |
|  | **Post-Effective Amendment No. 2 to Registration Statement on Form F-1** |
|  | **File No. 333-277725** |

---

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended (the "**Act**"), Jyong Biotech Ltd. (the "**Company**") respectfully requests that the effective date of the registration statement referred to above (the "**Registration Statement**") be accelerated so that it will become effective at 4:00 p.m., Eastern Time, on Monday, June 16, 2025, or as soon thereafter as possible. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.

Once the Registration Statement is effective, please orally confirm the event with our counsel, Sichenzia Ross Ference Carmel LLP by calling Shane Wu, Esq. at (202) 322-8852. We also respectfully request that a copy of the written order from the Securities and Exchange Commission verifying the effective time and date of the Registration Statement be sent to our counsel, Sichenzia Ross Ference Carmel LLP, Attention: Shane Wu, Esq, by email at swu@srfc.law and Tomer Magid, by email at tmagid@srfc.law.

If you have any questions regarding this request, please contact Shane Wu, Esq. of Sichenzia Ross Ference Carmel LLP, at (202) 322-8852.

---

| | |
|:---|:---|
| Very Truly Yours, | Very Truly Yours, |
| *By:* | */s/* Fu-Feng Kuo |
| Name: | Fu-Feng Kuo |
| Title: | Chief Executive Officer |

---

cc: Shane Wu, Esq. of Sichenzia Ross Ference Carmel LLP